Blood Cancer

Natural Cancer Supplement: Cell Forte with IP-6 and Inositol by Enzymatic Therapy

Wed, 13 Feb 2008 03:46:35 +0100

Cell Forte with IP-6 is a unique combination of inositol and inositol hexaphosphate (IP-6). Together, inositol and IP-6 create a remarkable increase in natural killer cell activity and enhances natural cellular defenses. Both inositol and IP-6 are found naturally in the cells of the body. However, studies show that by supplementing with Cell Forte, the cells become stronger.

The association of blood lead level and cancer mortality among whites in the United States. .

Lead is classified as a possible carcinogen in humans. We studied the relationship of blood lead level and all cancer mortality in the general population of the United States using data from the National Health and Nutrition Examination Survey IIMortality Study, 1992, consisting of a ...

Fred Hutchinson Oversees Two Grants Totaling Nearly $8 Million to Develop Blood Test for Breast Cancer.

Byline: Fred Hutchinson Cancer Research Center SEATTLE, Oct. 3- The Fred Hutchinson Cancer Research Center will oversee two major grants totaling nearly $8 million to develop a blood test that can be used in conjunction with mammography to improve early detection of breast ...

Blood test for detecting breast cancer shows promise. .

SAN ANTONIO-Asimple blood test for breast cancer detection that's substantially more accurate than mammography is drawing closer to clinical reality. And that's not all. The same proteomics technology being harnessed to detect breast cancer using a single drop of a patient's blood is also yielding ...

New England Journal of Medicine Publishes Study Showing Significant Reduction in Blood Clots in Cancer Patients; - Anticoagulant injections significantly reduced incidence of recurrent blood clots, which are common and serious complications of cancer -.

HAMILTON, ON, July 10 /PRNewswire/ - McMaster University researchers announced today that cancer patients with newly diagnosed blood clots who took an anticoagulantinjection developed half as many recurrent blood clots compared to patients taking standard oral anticoagulant ...

Matritech's Nuclear Matrix Proteins Detected in Blood of Women With Early Stage Breast Cancer.

Development of Blood Based Screening Test for Breast Cancer Proceeding on Schedule NEWTON, Mass., March 2 /PRNewswire/ - Matritech, Inc. , a company specializing in products designed to detect, manage and screen for cancer, announced today that its scientists had detected the ...

New England Journal of Medicine publishes study showing significant reduction in blood clots in cancer patients.

Hamilton, Ontario, July 10 /PRNewswire/ - - Anticoagulant injections significantly reduced incidence of recurrent blood clots, which are common and serious complications of cancer McMaster University researchers announced today that cancer patients with newly diagnosed blood clots who took an ...

Blood test for colon cancer risk may lessen need for colonoscopies

Blood test for colon cancer risk may lessen need for colonoscopies By MARILYNN MARCHIONE mmarchione@journalsentinel.com, Journal Sentinel Friday, March 14, 2003 For the first time, a simple blood test shows promise in helping predict the average person's risk of developing the most common form of ...

Blood Test For Cancer Has Promise; Experimental Method Is Fast, Inexpensive

Research on a new blood test that apparently can distinguish people with cancer from those who are healthy or who have other diseases suggests that the test may someday provide a rapid, inexpensive way of detecting malignancy, a Harvard scientist reported here last week. But many more studies will ...

Matritech's Blood-Based Colon Cancer Test Continues to Detect All Cases of Cancer.

Protein detected in blood of all 37 cancer patients tested; Also present in blood of people with high-risk polyps NEWTON, Mass., Nov. 20 /PRNewswire/ - Matritech Inc. , a company using proprietary seroproteomics discovery processes to identify and commercialize proteins for earlier ...

Cancer Society questions test to find tumors / Denver biochemist plans simple blood screenings

DENVER - A simple blood test that a Denver biochemist says accurately detects early-stage cancer may not be specific enough to aid in detection, an American Cancer Society official said Wednesday. The test, developed by Stuart Gordon, a biochemist at the University of Colorado Health Sciences ...